Abstract

ObjectivesThe current study aimed to design an ultra-low-dose CT examination protocol using a deep learning approach suitable for clinical diagnosis of COVID-19 patients.MethodsIn this study, 800, 170, and 171 pairs of ultra-low-dose and full-dose CT images were used as input/output as training, test, and external validation set, respectively, to implement the full-dose prediction technique. A residual convolutional neural network was applied to generate full-dose from ultra-low-dose CT images. The quality of predicted CT images was assessed using root mean square error (RMSE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Scores ranging from 1 to 5 were assigned reflecting subjective assessment of image quality and related COVID-19 features, including ground glass opacities (GGO), crazy paving (CP), consolidation (CS), nodular infiltrates (NI), bronchovascular thickening (BVT), and pleural effusion (PE).ResultsThe radiation dose in terms of CT dose index (CTDIvol) was reduced by up to 89%. The RMSE decreased from 0.16 ± 0.05 to 0.09 ± 0.02 and from 0.16 ± 0.06 to 0.08 ± 0.02 for the predicted compared with ultra-low-dose CT images in the test and external validation set, respectively. The overall scoring assigned by radiologists showed an acceptance rate of 4.72 ± 0.57 out of 5 for reference full-dose CT images, while ultra-low-dose CT images rated 2.78 ± 0.9. The predicted CT images using the deep learning algorithm achieved a score of 4.42 ± 0.8.ConclusionsThe results demonstrated that the deep learning algorithm is capable of predicting standard full-dose CT images with acceptable quality for the clinical diagnosis of COVID-19 positive patients with substantial radiation dose reduction.Key Points• Ultra-low-dose CT imaging of COVID-19 patients would result in the loss of critical information about lesion types, which could potentially affect clinical diagnosis.• Deep learning–based prediction of full-dose from ultra-low-dose CT images for the diagnosis of COVID-19 could reduce the radiation dose by up to 89%.• Deep learning algorithms failed to recover the correct lesion structure/density for a number of patients considered outliers, and as such, further research and development is warranted to address these limitations.

Highlights

  • The emergence of a novel coronavirus in December 2019 in Wuhan, China, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was recognized as a global public health concern by the World Health Organization (WHO) [1]

  • Ultra-low-dose computed tomography (CT) imaging of COVID-19 patients would result in the loss of critical information about lesion types, which could potentially affect clinical diagnosis

  • The root mean square error (RMSE) in units of normalized HU decreased from 0.16 ± 0.05 to 0.09 ± 0.02 and from 0.16 ± 0.06 to 0.08 ± 0.02 for predicted full-dose images from ultra-low-dose CT images in test and external validation set, respectively

Read more

Summary

Introduction

The emergence of a novel coronavirus in December 2019 in Wuhan, China, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was recognized as a global public health concern by the World Health Organization (WHO) [1]. SARS-CoV-2 disease 2019 or COVID-19 is an infectious disease that affects the upper and lower respiratory tract and induces mild to severe respiratory syndromes, including pneumonia [2]. Real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard method for COVID-19 diagnosis but is prone to a number of limitations, including the time of preparation and false-positive and falsenegative rates in different clinical samples [3]. Early studies confirmed that computed tomography (CT) is a feasible approach for COVID-19 diagnosis [4]. A wide range of clinical studies have been conducted on the feasibility of CT findings in the early detection and management of COVID-19 patients. There are still considerable knowledge gaps in the recognition of CT features linked to COVID-19 [4, 5]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call